Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication [Phase 4]
This Phase 4 clinical trial is evaluating the efficacy of 10-day versus 14-day bismuth-based quadruple therapy as first-line treatment for H…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy [Phase 4]
A Phase 4 clinical trial update indicates ongoing activity evaluating Lacidophilin Tablets in combination with Vonorazan Dual Therapy for He…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication [Phase 4]
This Phase 4 trial reports on the efficacy and safety of a dual therapy regimen for Helicobacter pylori eradication, and the study is comple…
-
FDA approval · 2024-06-12FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for the fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin from Rising Pharma H…
-
FDA approval · 2024-06-11FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin. The product i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection [NA]
A completed clinical trial evaluating esomeprazole or vonoprazan combined with high-dose amoxicillin dual therapy for primary eradication of…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Intrafamilial Helicobacter Pylori Infection in Hong Kong [NA]
A Hong Kong clinical trial is examining intrafamilial Helicobacter pylori infection, with the study currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori [Phase 3]
Phase 3 trial evaluating vonoprazan for eradication of resistant Helicobacter pylori strains. The study has completed.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study) [Phase 4]
Phase 4 clinical trial evaluating Helicobacter pylori eradication using DPO-PCR methods (K-CREATE study) and currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Optimal Tailored Treatment for H. Pylori Infection [NA]
The clinical trial investigating tailored treatment for Helicobacter pylori infection has been withdrawn. No results are reported.
-
CLINICAL_TRIALS other · 2024-05-14Clinical Trial Update: Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori [Phase 4]
A Phase 4 clinical trial evaluating optimization of Keverprazan-amoxicillin dual therapy for Helicobacter pylori infection. The study is cur…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection
A clinical trial evaluating the use of white light endoscopy with magnifying endoscopy to assess the status of Helicobacter pylori infection…
-
FDA approval · 2024-05-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole from Mylan Pharmaceuticals Inc., indicating an amendment to the approved generic pr…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Tegoprazan-containing Sequential for H. Pylori [NA]
A clinical trial evaluating tegoprazan-containing sequential therapy for Helicobacter pylori infection is currently recruiting at Seoul Nati…
-
FDA approval · 2024-05-01FDA Approved: TALICIA — Supplemental Application (RedHill Biopharma Ltd)
The FDA approved a supplemental application for TALICIA, a fixed-dose combination of omeprazole magnesium, amoxicillin, and rifabutin develo…
-
FDA approval · 2024-05-01FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for VOQUEZNA TRIPLE PAK (vonoprazan fumarate, amoxicillin, and clarithromycin). The approval exp…
-
FDA approval · 2024-05-01FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
FDA approved a supplemental application to authorize Voquezna Dual Pak, a fixed-dose combination of vonoprazan fumarate and amoxicillin, for…
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amoxicillin submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia [Phase 2, Phase 3]
Clinical trial update reporting efficacy and safety of Lacidofil STRONG as an adjuvant in Helicobacter pylori treatment in non-ulcer dyspeps…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 trial comparing optimized bismuth quadruple therapy versus triple standard therapy for Helicobacter pylori eradication has been comp…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of a bismuth quadruple therapy containing cefuroxime and tetracycline as first-lin…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses [Phase 4]
Phase 4 trial update evaluating bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection using differe…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole [Phase 4]
Phase 4 trial comparing a tegoprazan-based triple eradication therapy to esomeprazole for Helicobacter pylori infection; efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians [Phase 4]
A Phase 4 clinical trial evaluating safety and efficacy of triple and quadruple regimens as first-line therapy for Helicobacter pylori infec…
-
FDA approval · 2024-02-23FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for Lansoprazole submitted by Medcore LLC. The snippet does not specify the exact changes covere…